Skip to main content
PMC home page
BMC Medical Genetics logoLink to BMC Medical Genetics
. 2014 Jul 23;15:84. doi: 10.1186/1471-2350-15-84

Molecular characterization of a Chinese family carrying a novel C4329A mutation in mitochondrial tRNAIle and tRNAGln genes

Yuqi Liu 1,#, Yang Li 1,#, Jinliao Gao 1,#, Chao Zhu 1, Yunfeng Lan 1, Jie Yang 1, Zongbin Li 1, Minxin Guan 2,3,4,✉, Yundai Chen 1,✉
PMCID: PMC4120007  PMID: 25056089

Abstract

Background

Hypertension is a very common cardiovascular disease influenced by multiple genetic and environmental factors. More recently, there are some studies showed that mutations in mitochondrial DNA have been involved in its pathogenesis. In this study we did further investigations on this relationship.

Methods

Epidemiological research found a Han Chinese family with probable maternally transmitted hypertension. Sequence analysis of the whole mitochondrial DNA was detected from all the family members. And evaluations of the clinical, genetic and molecular characterization were also performed.

Results

Matrilineal relatives within the family exhibited varying degrees of hypertension with an onset age of 48–55 years. Sequence analysis of this pedigree showed a novel homoplasmic 4329C > G mutation located at the 3’ end of the tRNAIle and tRNAGln genes that was absent from 366 Chinese controls. The cytosine (C) at 4329 position was very important in the structural formation and stabilization of functional tRNAs, which was highly conserved in mitochondria of various organisms and also contributed to the high fidelity of the acceptor arm. Cells carrying this mutation were also shown to harbor mitochondrial dysfunctions.

Conclusions

The C4329G point mutation in tRNAIle and tRNAGln was involved in the pathogenesis of hypertension, perhaps in association with other modifying factors.

Keywords: Mitochondria, Hypertension, Mutation, tRNA

Background

Essential hypertension (EH) is one of the most important modifiable risk factors for cardiovascular disease (CVD) and renal disease in worldwide. In China, there is a prevalence estimate of 27.9%, or 133 million, hypertensive adults [1]. Hypertension is also a major risk factor for the development of CVD and renal morbid- and fatal events [2].

The etiology of hypertension is not well understood because it can be caused by single or multiple genetics, and also associated with environmental and other individual factors. Of the genetic factors, maternal transmission of hypertension has been implicated in some pedigrees, suggesting that mutations in mitochondrial DNA (mtDNA) may contribute to the pathogenesis of EH [3-7]. More recently, several mtDNA point mutations have been proved in association with hypertension. These mutations include T3308C in ND1[8], A4435G in tRNAMet[9], A4295G and A4263G in tRNAIle[10,11], and A4401G in tRNAMet and tRNAGln[12].

To identify novel mtDNA mutations involved in the pathogenesis of hypertension in Chinese population, we initiated a systematic and extended mutational screening of mtDNA in a large cohort of hypertension subjects from the Geriatric Cardiology Clinic at the Chinese PLA General Hospital. Here, we reported a novel point mutation C4329G in tRNAIle and tRNAGln genes carried by a Chinese Han family with maternally inherited hypertension.

Methods

Subjects

As part of a genetic screening program for hypertension, a Chinese Han family with maternal inherited hypertension was found at the Institute of Geriatric Cardiology at the Chinese PLA General Hospital. An experienced physician measured the systolic and diastolic blood pressures of subjects with a mercury column sphygmomanometer using a standard protocol. The first and the fifth Korotkoff sounds were taken to be indicative of systolic and diastolic blood pressures, respectively. The average of three such readings was taken as the examination blood pressure. Hypertension was defined according to the recommendation of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI) [13] as a systolic blood pressure of 140 mmHg or higher and /or a diastolic blood pressure of 90 mmHg or greater. All the members of this family underwent a thorough physical examination, a laboratory assessment of CVD risk factors, and routine electrocardiography (Figure 1). All subjects were evaluated to identify both personal and medical histories of hypertension and other clinical abnormalities. DNA samples of the family and 366 healthy controls were aquired for sequence analysis. Informed consents were obtained from all participating members, under protocols approved by the ethics committee of the Chinese PLA General Hospital.

Figure 1.

Figure 1

Open in a new tab

Pedigree chart of the Chinese family with hypertension. Affected individuals are indicated by filled symbols. Arrowhead denotes proband.

mtDNA sequencing and analysis

Genomic DNA was isolated from whole blood cells of participants using Puregene DNA Isolation Kits (Gentra Systems, Minneapolis, MN). The entire mitochondrial genome of all the participants were PCR-amplified in 24 overlapping fragments using sets of light-strand and heavy-strand oligonucleotide primers [14]. Each fragment was purified and subsequently analyzed by direct sequencing in an ABI 3700 automated DNA sequencer (Applied Biosystems, Inc., Foster City, CA) using the Big Dye Terminator Cycle sequencing reaction kit. The resultant sequence data were compared with the revised consensus Cambridge sequence (GenBank accession no. NC-012920) [15]. All mtDNA mutations were individually analyzed using the MitoAnalyzer (National Institutes of Standards and Technology, Gaithersburg, MD; http://www.cstl.nist.gov/biotech/strbase/mitoanalyzer.html) and the MITOMAP database [16]. The haplogroups were deduced by comparing the complete mtDNA sequence data with previously reported haplogroup-specific variants [17].

Results

Clinical presentation

The proband (II-2) presented with essential hypertension with onset age of 50 years old. Her medical history reported a highest blood pressure reading of 220/120 mm Hg. She first underwent full evaluation at the Chinese PLA General Hospital Geriatric Cardiology Clinic at the age of 60 with a blood pressure 160/80 mm Hg. She suffered from headaches when her blood pressure exceeded 200/100 mmHg, and took oral reserpine and aspirin to prevent stroke when it ranged between 140/80 and 160/100 mmHg. She was diagnosed with diabetes mellitus two years ago for which she was administered oral metformin. Laboratory tests showed a normal range of liver function, normal cholesterol levels, and mild kidney dysfunction (creatinine clearance rate, 81.2 ml/min). Kidney dysfunction was secondary to hypertension. The ECG showed left ventricular hypertrophy. Physical examination revealed no other clinical abnormalities, including hyperlipidemia, vision and hearing impairments, and neurological disorders associated with mitochondrial DNA muation.

The proband’s family located in Shanxi Province in Northern China (shown in Figure 1), the family presented with a maternal inheritance of hypertension. Her mother (I-2) was diagnosed with hypertension at 60 years of age, with a blood pressure of 180/100 mm Hg. She has three brothers and three sisters; one brother (II-13) and one sister (II-8) presented with high blood pressure at the age of 48 years and 55 years, respectively. One of her nieces (III-7) and one of her nephew (III-5) also had hypertension with an onset age of 43 and 40 years old. None of the offspring of the affected father had hypertension. The clinical data of other family members were showed in Table 1.

Table 1.

Summary of clinical data of the members in the Chinese Pedigree

Subjects Gender Age of test (yrs) Age of onset (yrs) Systolic pressure (mmHg) Diastolic pressure (mmHg) IVST, mm(6-12 mm) ECG CCr (ml/min)
II-1
 M
 63
 -
 132
 60
 10
 N
 89.1
II-2*
 F
 60
 50
 160
 80
 12
 LVH
 81.2
II-3
 M
 61
 -
 128
 68
 11
 N
 102.8
II-4
 F
 58
 -
 120
 60
 10
 N
 103.5
II-5
 M
 68
 -
 124
 58
 9
 N
 87.9
II-6
 F
 62
 -
 130
 60
 10
 N
 86.5
II-7
 M
 70
 -
 132
 70
 10
 N
 92.6
II-8*
 F
 64
 55
 150
 80
 12
 LVH
 72.3
II-9
 M
 56
 -
 128
 64
 9
 N
 82.3
II-10
 F
 52
 -
 120
 66
 11
 N
 87.4
II-11
 M
 53
 -
 124
 60
 10
 N
 92.7
II-12
 F
 50
 -
 132
 68
 11
 N
 86.9
II-13*
 M
 54
 48
 140
 100
 11
 N
 83.2
II-14
 F
 50
 -
 128
 60
 9
 N
 119.2
III-1
 M
 40
 -
 130
 60
 8
 N
 122.3
III-2
 M
 38
 -
 128
 58
 8
 N
 130.2
III-3
 F
 35
 -
 118
 60
 9
 N
 118.6
III-4
 M
 33
 -
 120
 58
 9
 N
 108.6
III-5
 M
 40
 40
 150
 90
 12
 N
 89.1
III-6
 M
 39
 -
 124
 60
 9
 N
 121.3
III-7
 F
 44
 43
 160
 90
 13
 LVH
 71.2
III-8
 M
 30
 -
 116
 60
 8
 N
 114.5
III-9
 F
 28
 -
 128
 70
 9
 N
 134.8
III-10
 M
 28
 -
 126
 70
 9
 N
 107.9
III-11
 M
 25
 -
 130
 70
 10
 N
 126.7
III-12 F 27 - 120 58 9 N 139.6
Open in a new tab

*These patients received antihypertension treatment. This table shows pretreatment blood pressures. CCr indicates endogenous creatinine clearance; F, female; M, male; IVST, interventricular septal thickness; LVH, ECG showed left ventricular hypertrophy; N, electrocardiography (ECG) was normal.

Mitochondrial DNA analysis

Since the transmission pattern of this family presented with maternal inherited hypertension, we supposed that mtDNA maybe involved in the pathogenesis. So we did further analyze on the mitochondrial genome of the family members. We did analyze on the entire mitochondrial gene using PCR amplification and subsequent sequence analysis of PCR fragments derived from proband II-2 and an unrelated Chinese control. As shown in Figure 2B, the point mutation C4329G in tRNAIle and tRNAGln genes was identified in the proband. Sequencing of the PCR fragment spanning the tRNAIle and tRNAGln genes revealed that this mutation was absent from 366 Chinese controls.

Figure 2.

Figure 2

Open in a new tab

Identification and qualification of the 4329C > G mutation at the junction between mitochondrial tRNAIle and tRNAGln genes. (A) Schema of the location of 4329C > G in the precursors of tRNAIle and tRNAGln genes. Cloverleaf structures of human mitochondrial tRNAIle and tRNAGln are derived from Florentz et al. [4]. Processing sites in the mitochondrial tRNAIle and tRNAGln precursors were determined for RNase Z. Arrow indicates the position of the 4329C > G mutation. (B) Partial sequence chromatograms of tRNAIle and tRNAGln genes from an affected individual (II-2) and a married-in control (II-1). Arrow indicates the location of the base changes at position 4329.

And all the family members had did sequence analysis. All the 14 maternal lineage except the pedigree (I-2), carried the C4329G mutation in tRNAIle and tRNAGln genes. The other non-maternal members had no this point mutation. And in these 14 maternal members, there are 5 of them had presented with hypertension. More important, her nieces (III-7) and nephew (III-5) also had hypertension with an onset age of 43 and 40 years old, respectively. And it is very important that none of the offspring of the affected father carried this point muation. We also did segregation analysis on the pedigree, and except for autosomal recessive, autosomal dominant, X-linked patterns. By far the mitochondrial point mutation is the most likely explanation of etiology of hypertension for this pedigree.

The C4329G mutation, as shown in Figure 2A, is located at the 3’ end of the acceptor arm of tRNAIle and tRNAGln[4,18]. Figure 3 presented us that the cytosine residue at this position is highly conserved in all known tRNAIle and tRNAGln sequences [4,18]. In fact, nucleoside modifications at this position play a pivotal role in the stabilization of the tertiary structure and the tRNAs’ function [19]. The C4467A mutation in tRNAMet gene which was evolutionary conserved, but was not detected in other maternal members.

Figure 3.

Figure 3

Open in a new tab

Alignment of tRNAIle genes from different species. Arrow indicates the position of the Acc-stem 71 at the anticodon loop of tRNA, corresponding to the C > G at position 4329.

To further identify the phenotypic manifestation, DNA fragments spanning the entire mtDNA of the proband II-2 were PCR-amplified. Each fragment was purified and subsequently analyzed by direct sequencing. As shown in Table 2, a comparison of the resultant sequences with the Cambridge consensus sequence and control subject identified a number of nucleoside changes belonging to the Eastern Asian haplogroup H2 [20]. These included eight polymorphisms in the D-loop region, three variants in the 12S rRNA gene, one in the 16S rRNA gene, two in the ND1 gene, a C4329G mutation in the tRNAIle and tRNAGln genes, one variant in the COII gene, one in the COIII gene, one in each of the ATPase6 and ATPase8 genes, two in the each of the ND3 and ND4 genes, and four in each of the ND6 and Cytb genes [21]. Those tRNA, rRNA, and polypeptide variants were further evaluated by phylogenetic analysis of sequences from other organisms such as mouse [22], cow [23] and Xenopus laevis[24]. However, none of the polypeptide variants were highly conserved evolutionarily, indicating that they do not have a significant functional consequence.

Table 2.

mtDNA variants in 1 Han Chinese subject (II-2) with hypertension and 1 Han Chinese control subject

Gene Position Replacement Conservation (H/M/B/X)* rCRS† II-2 Control Previously reported‡ Amino acid change
D-loop
 73
 A to G
  
 A
 G
 G
 Y
  
 
 152
 T to C
  
 T
 C
 C
 Y
  
 
 263
 A to G
  
 A
 G
 G
 Y
  
 
 310
 T to C
  
 T
 C
 C
 Y
  
 
 489
 T to C
  
 T
 C
 C
 Y
  
12SrRNA
 1382
 A to C
 A/G/G/C
 A
 C
 C
 Y
 rRNA
 
 1438
 A to G
 A/A/C/A
 A
 G
 G
 Y
 rRNA
16SrRNA
 2706
 A to G
 A/G/G/A
 A
 G
 G
 Y
 rRNA
 
 3010
 G to A
 G/T/G/A
 G
 A
 A
 Y
 rRNA
ND1
 3975
 C to T
 C/C/A/C
 C
 T
 C
 Y
 syn
 
 4260
 C to T
 C/M/C/T
 C
 T
 T
 Y
 syn
tRNA Ile
 4329
 C to G
 C/C/C/C
 C
 G
 C
 N
  
tRNA Met
 4467
 C to A
 C/C/C/C
 C
 A
 C
 N
  
COII
 8020
 G to A
 G/P/C/A
 G
 A
 A
 Y
 syn
ATPase8
 8414
 C to T
 C/A/C/A
 C
 T
 T
 Y
 L-F
ATPase6
 8701
 A to G
 A/I/F/T
 A
 G
 G
 Y
 T-A
COIII
 9824
 T to A
 T/F/L/C
 T
 A
 A
 Y
 syn
ND3
 10398
 A to G
 A/E/E/A
 A
 G
 G
 Y
 T-A
 
 10400
 C to T
 C/I/T/E
 C
 T
 T
 Y
 syn
ND4
 10873
 T to C
 T/T/T/C
 T
 C
 C
 Y
 syn
 
 11984
 T to A
 T/A/S/T
 T
 A
 T
 Y
 Y-H
ND6
 14580
 A to T
  
 A
 T
 T
 Y
 syn
 
 14587
 A to C
  
 A
 C
 C
 Y
 syn
 
 14605
 A to G
  
 A
 G
 G
 Y
 syn
 
 14668
 C to T
  
 C
 T
 T
 Y
 syn
Cytb
 14783
 T to C
 T/F/K/A
 T
 C
 C
 Y
 syn
 
 15043
 G to A
  
 G
 A
 A
 Y
 syn
 
 15301
 G to A
  
 G
 A
 A
 Y
 syn
 
 15326
 A to G
 A/L/S/A
 A
 G
 G
 Y
 T-A
D-loop
 16223
 C to T
  
 C
 T
 T
 Y
  
 
 16311
 T to C
  
 T
 C
 C
 Y
  
  16362 T to C   T C C Y  
Open in a new tab

*Data show the conservation of amino acid for polypeptides or nucleotide for rRNAs, in human (H), mouse (M), bovine (B), and Xenopus laevis (X).

†Cambridge sequence.

‡See http://www.mitomap.org.

Discussion

EH is currently regarded as a multifactorial CVD, which may be influenced by both genetic and/or environmental factors. The role of genetic factors in the etiology of hypertension is improved by cross-sectional studies of familial aggregation of the disorder despite exposure to different environmental factors [10,25]. Estimates of genetic variance range from 20–50% [26], and significant blood pressure correlations between mothers and offspring or excess maternal transmission of hypertension have been noted in several earlier [8,25] and more recent [8-12] investigations.

In this study, we performed the clinical, genetic molecular investigation of a Chinese family with hypertension. Hypertension as a sole clinical phenotype was only presented in all matrilineal relatives of this three-generation pedigree, suggesting that the mtDNA mutation (s) is involved in this disorder. Mutational analysis of the mitochondrial genome identified the novel mutation 4329C > G in tRNAIle and tRNAGln in matrilineal relatives of this Chinese family. The absence of this mutation from 366 Chinese controls strongly suggests that it is involved in the pathogenesis of hypertension. There are 32 variants identified belonging to the Eastern Asian haplogroup H2 on the maternal lineage. Thirty variants were the known polymorphisms, 4329C > G and 4467C > A were novel variants, but 4467C > A were not identified in other maternal members (not detected in II-8, II-13). The 4329C > G is located in the acceptor arm of tRNAIle and tRNAGln, which is a 7-base pair stem made by the base pairing of the 5′-terminal nucleotide with the 3′-terminal nucleotide. This contains the CCA 3′-terminal group that is used to attach the amino acid. Pre-tRNA 3’ ends are subsequently completed by the addition of the CCA triplet, and a subset of nucleotides becomes post-transcriptionally modified. Finally, mature and correctly folded tRNAs are esterified at the 3’ end with the cognate amino acid by the corresponding aminoacyl-tRNA synthetase. These are subsequently transported to the ribosome by the translation factor elongation factor (EF)-Tu, enabling protein synthesis to occur. In addition, 4329 was located at the cleavage sites of tRNAase Z, so this substitution could impair (or not) the cleavage and processing of the policistronic mtRNA transcripts into mature mt-tRNA species. Thus, 3’ end metabolism is important for both tRNA synthesis and function, as shown by a previous report by Guan et al. in which a Chinese family with Leber’s hereditary optic neuropathy was found to be associated with the homoplasmic A15951G mutation located adjacent to the 3’ end [27].

Conclusions

In summary, the occurrence of the 4329C > G mutation in the Chinese Han family pedigree with hypertension and its absence in 366 Chinese controls and the observed mitochondrial dysfunctions in cells carrying the mutation suggest that it is involved in the pathogenesis of hypertension. However, as hypertension is a complex CVD associated with multiple genetic and environmental factors, disease pathogenesis may result from this point mutation in association with other modifier factors.

Abbreviations

EH: Essential hypertension; mtDNA: mitochondrial DNA; ECG: Electrocardiography.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

JG, YLan carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY, ZL, CZ carried out the immunoassays. YLi and MG drafted the manuscript. YLi, MG and YC designed the whole experiments. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2350/15/84/prepub

Contributor Information

Yuqi Liu, Email: ametuofo4290@gmail.com.

Yang Li, Email: yangli@163.com.

Jinliao Gao, Email: gaojl@163.com.

Chao Zhu, Email: zhuchao@163.com.

Yunfeng Lan, Email: lanyf@163.com.

Jie Yang, Email: yangjie@gmail.com.

Zongbin Li, Email: zongbl@163.com.

Minxin Guan, Email: gminxin88@gmail.com.

Yundai Chen, Email: ametuofo980869@163.com.

Acknowledgements

This work was supported by grants from the National Science Foundation of China to Y.L. (no: 81030002) and Y.Q. Liu (no: 81100186/H0214).

References

  1. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds RF, Su S, Whelton PK, He J. InterASIA Collaborative Group. The international collaborative study of cardiovascular disease in Asia: prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;15(6):920–927. doi: 10.1161/01.hyp.0000040263.94619.d5. [DOI] [PubMed] [Google Scholar]
  2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;15(6):1206–1252. doi: 10.1161/01.HYP.0000107251.49515.c2. [DOI] [PubMed] [Google Scholar]
  3. Watson B Jr, Khan MA, Desmond RA, Bergman S. Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease. Am J Kidney Dis. 2001;15(3):529–536. doi: 10.1053/ajkd.2001.26848. [DOI] [PubMed] [Google Scholar]
  4. Florentz C, Sohm B, Tryoen-Toth P, Putz J, Sissler M. Human mitochondrial tRNAs in health and disease. Cell Mol Life Sci. 2003;15(7):1356–1375. doi: 10.1007/s00018-003-2343-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hirano M, Davidson M, DiMauro. Mitochondria and the heart. Curr Opin Cardiol. 2001;15(3):201–210. doi: 10.1097/00001573-200105000-00008. [DOI] [PubMed] [Google Scholar]
  6. Schwartz F, Duka A, Sun F, Cui J, Manolis A, Gavras H. Mitochondrial genome mutations in hypertensive individuals. Am J Hypertens. 2004;15(7):629–635. doi: 10.1016/j.amjhyper.2004.02.020. [DOI] [PubMed] [Google Scholar]
  7. Zinner SH, Levy PS, Kass EH. Familial aggregation of blood pressure in childhood. N Engl J Med. 1971;15(8):401–404. doi: 10.1056/NEJM197102252840801. [DOI] [PubMed] [Google Scholar]
  8. Liu Y, Li Z, Yang L, Wang S, Guan MX. The mitochondrial ND1 T3308C mutation in a Chinese family with the secondary hypertension. Biochem Biophys Res Commun. 2008;15(1):18–22. doi: 10.1016/j.bbrc.2007.12.193. [DOI] [PubMed] [Google Scholar]
  9. Liu Y, Li R, Li Z, Wang XJ, Yang L, Wang S, Guan MX. Mitochondrial transfer RNAMet 4435A > G mutation is associated with maternally inherited hypertension in a Chinese pedigree. Hypertension. 2009;15(6):1083–1090. doi: 10.1161/HYPERTENSIONAHA.109.128702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Li Z, Liu Y, Yang L, Wang S, Guan MX. Maternally inherited hypertension is associated with the mitochondrial tRNAIle A4295G mutation in a Chinese family. Biochem Biophys Res Commun. 2008;15(4):906–911. doi: 10.1016/j.bbrc.2007.12.150. [DOI] [PubMed] [Google Scholar]
  11. Wang S, Li R, Fettermann A, Li Z, Qian Y, Liu Y, Wang X, Zhou A, Mo JQ, Yang L, Jiang P, Taschner A, Rossmanith W, Guan MX. Maternally inherited essential hypertension is associated with the novel 4263A > G mutation in the mitochondrial tRNAIle gene in a large Han Chinese family. Circ Res. 2011;15(7):862–870. doi: 10.1161/CIRCRESAHA.110.231811. [DOI] [PubMed] [Google Scholar]
  12. Li R, Liu Y, Li Z, Yang L, Wang S, Guan MX. Failures in mitochondrial tRNAMet and tRNAGln metabolism caused by the novel 4401A > G mutation are involved in essential hypertension in a Han Chinese family. Hypertension. 2009;15(2):329–337. doi: 10.1161/HYPERTENSIONAHA.109.129270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. National High Blood Pressure Education Program Coordinating Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1997;15(21):2413–2446. doi: 10.1001/archinte.157.21.2413. [DOI] [PubMed] [Google Scholar]
  14. Rieder MJ, Taylor SL, Tobe VO, Nickerson DA. Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome. Nucleic Acids Res. 1998;15(4):967–973. doi: 10.1093/nar/26.4.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG. Sequence and organization of the human mitochondrial genome. Nature. 1981;15(5806):457–465. doi: 10.1038/290457a0. [DOI] [PubMed] [Google Scholar]
  16. Wallace DC, Lott MT. MITOMAP: a human mitochondrial genome database. 2013. Available at: http://www.mitomap.org. Accessed 2013. [DOI] [PMC free article] [PubMed]
  17. Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE, Howell N. Reduced median-network analysis of complete mitochondrial DNA coding region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet. 2002;15(5):1152–1171. doi: 10.1086/339933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sprinzl M, Horn C, Brown M, Ioudovitch A, Steinberg S. Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res. 1998;15(1):148–153. doi: 10.1093/nar/26.1.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bjork GR. In: tRNA: Structure, Biosynthesis and Function. Soll D, RajBhandary UL, editor. Washington, DC: ASM Press; 1995. tRNA: structure, biosynthesis and function; pp. 165–206. [Google Scholar]
  20. Tanaka M, Cabrera VM, González AM, Larruga JM, Takeyasu T, Fuku N, Guo LJ, Hirose R, Fujita Y, Kurata M, Shinoda K, Umetsu K, Yamada Y, Oshida Y, Sato Y, Hattori N, Mizuno Y, Arai Y, Hirose N, Ohta S, Ogawa O, Tanaka Y, Kawamori R, Shamoto-Nagai M, Maruyama W, Shimokata H, Suzuki R, Shimodaira H. Mitochondrial genome variation in eastern Asia and the peopling of Japan. Genome Res. 2004;15(10A):1832–1850. doi: 10.1101/gr.2286304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Brandon MC, Lott MT, Nguyen KC, Spolim S, Navathe SB, Baldi P, Wallace DC. MITOMAP: a human mitochondrial genome database – 2004 update. Nucleic Acids Res. 2005;15(Database issue):D611–D613. doi: 10.1093/nar/gki079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Bibb MJ, Van Etten RA, Wright CT, Walberg MW, Clayton DA. Sequence and gene organization of mouse mitochondrial DNA. Cell. 1981;15(2 Pt 2):167–180. doi: 10.1016/0092-8674(81)90300-7. [DOI] [PubMed] [Google Scholar]
  23. Gadaleta G, Pepe G, De Candia G, Quagliariello C, Sbisà E, Saccone C. The complete nucleotide sequence of the Rattus norvegicus mitochondrial genome: cryptic signals revealed by comparative analysis between vertebrates. J Mol Evol. 1989;15(6):497–516. doi: 10.1007/BF02602930. [DOI] [PubMed] [Google Scholar]
  24. Roe A, Ma DP, Wilson RK, Wong JF. The complete nucleotide sequence of the Xenopus laevis mitochondrial genome. J Biol Chem. 1985;15(17):9759–9774. [PubMed] [Google Scholar]
  25. Havlik RJ, Feinleib M. Epidemiology and genetics of hypertension. Hypertension. 1982;15(5 Pt 2):III121–III127. doi: 10.1161/01.hyp.4.5_pt_2.iii121. [DOI] [PubMed] [Google Scholar]
  26. Hunt SC, Hasstedt SJ, Kuida H, Stults BM, Hopkins PN, Williams RR. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol. 1989;15(3):625–638. doi: 10.1093/oxfordjournals.aje.a115175. [DOI] [PubMed] [Google Scholar]
  27. Li R, Qu J, Zhou X, Tong Y, Hu Y, Qian Y, Lu F, Mo JQ, West CE, Guan MX. The mitochondrial tRNA (Thr) A15951G mutation may influence the phenotypic expression of the LHON-associated ND4 G11778A mutation in a Chinese family. Gene. 2006;15(1):79–86. doi: 10.1016/j.gene.2006.02.014. [DOI] [PubMed] [Google Scholar]

Articles from BMC Medical Genetics are provided here courtesy of BMC

RESOURCES